Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 55 of 59, showing 10 Applications out of 584 total, starting on record 541, ending on 550

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

541.

ECCT/25/02/10   PrEP My Way II
    PrEP My Way: A hybrid type 1 clinical effectiveness-implementation trial to promote PrEP persistence among young Kenyan women   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
Site(s) in Kenya
KEMRI RCTP
 
17-06-2025 View

542.

ECCT/16/03/02   Infant TB Infection Prevention Study (“iTIPS”)
    Preventing Mycobacterium Tuberculosis Infection in HIV-Exposed Infants       
Principal Investigator(s)
1. Grace John-Stewart
Site(s) in Kenya
1. Kisumu East District Hospital (Kisumu county)
2. Ahero County Hospital (Kisumu county)
3. Bondo sub-County Hospital (Kisumu county)
 
03-06-2016 View

543.

ECCT/19/06/02   The A-PLUS study
    Prevention of Maternal and Neonatal Death/Infections with a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-Income Countries): a Randomized Controlled Trial   
Principal Investigator(s)
1. Prof Fabian Esamai Omoding Esamai
Site(s) in Kenya
1. Alupe, Sirisia, Bokoli (Bung\'oma county)
2. Nambale, Nasewa, Lukolis, Khunyangu (Busia county)
3. Mumias (Kakamega county)
 
09-06-2020 View

544.

ECCT/16/07/03   CYP STUDY
    Primaquine metabolism and its association with CYP2D6 and CYP2C19 genotypes among adults living within Seme and Kisumu West sub-counties of Kisumu County, Western Kenya       
Principal Investigator(s)
1. BEN ANDAGALU
2. BEN ANDAGALU
Site(s) in Kenya
KOMBEWA CLINICAL RESEARCH CENTRE
 
05-05-2017 View

545.

ECCT/21/02/02   RESHAPE
    PROSPECTIVE NON-INTERVENTIONAL MULTI-CENTER STUDY EVALUATING BLEEDING INCIDENCE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEMOPHILIA A WITH INHIBITORS AND NON-INHIBITORS TREATED WITH EMICIZUMAB AND OTHER HEMOPHILIA TREATMENTS IN A REAL-LIFE SETTING   
Principal Investigator(s)
1. Festus Njuguna
Site(s) in Kenya
Moi Teaching and Referral Hospital
 
12-05-2021 View

546.

ECCT/14/09/02   LIVING STUDY-PHASE III B.
    Prospective study of Lopinavir based ART for HIVInfected childreNGlobally (LIVING study)   
Principal Investigator(s)
1. Elizabeth Maleche Obimbo
2. Elizabeth Bukusi
3. Winstone Nyandiko
4. Bienvenu Baruani Ngoy
5. Joseph Kariuki Mbuthia
6. Allan Godfrey Otieno
7. Lucy Koech
8. Neema Mturi
9. Beatrice Mutai
Site(s) in Kenya
1. University of Nairobi/ Kenyatta National Hospital (Nairobi City county)
2. AMPATH, Moi University Teaching and Referral Hospital Eldoret (Uasin Gishu county)
3. MSF Belgium Kibera Clinic (Nairobi City county)
4. Gertrude\'s Children\'s Hospital (Nairobi City county)
5. Mbagathi District Hospital (Nairobi City county)
 
08-12-2014 View

547.

ECCT/08/27/12   MAL 55: A phase III, double blind (observer-blind), randomised, controlled multicenter study to evaluate, in infants and children, the efficacy of the RTS,S/AS01E candidate vaccine against malaria disease caused by P. falciparum infection.
    Protocol No. 110021 - MAL 55 STUDY   A phase III, double blind (observer-blind), randomised, controlled multicenter study to evaluate, in infants and children, the efficacy of the RTS,S/AS01E candidate vaccine against malaria disease caused by P. falciparum infection, across diverse malaria transmission settings in Africa”   
Principal Investigator(s)
1. Dr. Mary Hamel
2. Dr. Patricia Njuguna
3. Dr. Walter Otieno
Site(s) in Kenya
1. KEMRI - CDC RESEARCH INSTITUTION CENTRE, KISUMU (Kisumu county)
2. KEMRI-WELLCOME TRUST RESEARCH CENTER, KILIFI SITE (Kilifi county)
3. KEMRI-WALTERREED, RESEARCH CENTRE, KOMBEWA SITE (Kisumu county)
 
07-12-2012 View

548.

ECCT/15/06/01  
    Pyronaridine-artesunate and artemether-lumefantrine for the treatment of paediatric uncomplicated falciparum malaria in Western Kenya   
Principal Investigator(s)
1. Patrick Sawa
Site(s) in Kenya
St. Judes Clinic, ICIPE
 
04-09-2015 View

549.

ECCT/20/06/07   Quality of Oxytocin and TXA
    Quality of Oxytocin and Tranexamic acid in selected facilities in six countries   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
1. Mwingi Sub county (level 4 ) hospital (Kitui county)
2. Nyeri Level 5 Hospital (Nyeri county)
3. Garissa county referral hospital (Garissa county)
4. Embu Level 5 hospital (Embu county)
5. TIGONI LEVEL 4 HOSPTIAL (Kiambu county)
6. Meru Teaching and Referral Hospital (Meru county)
7. Kitengela Sub county Hospital (Kajiado county)
8. Mbagathi County Hospital (Nairobi City county)
9. Kakamega County Government Referral Hospital (Kakamega county)
10. St. Mary\'s Mission Hospital (Nairobi City county)
 
19-10-2020 View

550.

ECCT/25/07/06   SASI
    Randomized Controlled Trial of Surfactant Administered via Supraglottic Airway Device (SALSA) Compared to Endotracheal Tube (InSurE) on Survival without Mechanical Ventilation in Preterm Neonates with Respiratory Distress Syndrome in Sub-Saharan Africa   
Principal Investigator(s)
1. Mary Waiyego Kariuki
Site(s) in Kenya
Kenyatta national Hospital
 
31-10-2025 View